Back
HFA Premium Access

Natriuretic response to volume expansion and diuretics before and after initiation of sacubitril/valsartan in humans with heart failure

Session: Clinical Trial Updates
Topic: Pharmacotherapy
Speaker: Professor A. Mebazaa (Paris, FR)
Event: Heart Failure 2021

Congress Presentation

About the speaker

Professor Alexandre Mebazaa

Hospital Lariboisiere, Paris (France)
81 presentations
19 followers

13 more presentations in this session

Omecamtiv Mecarbil in Patients with Severe Heart Failure: An Analysis from Global Approach to Lowering Adverse Cardiac Outcomes through Improving Contractility in Heart Failure (GALACTIC-HF)

Speaker: Professor G. Felker (Durham, US)

Access
Slides
Video
Thumbnail

Association of Baseline Cardiac Biomarkers on Clinical Outcomes and Vericiguat Treatment Effect in Heart Failure with Reduced Ejection Fraction: Insights from the VICTORIA Trial

Speaker: Associate Professor C. DeFilippi (Baltimore, US)

Access
Slides
Video
Thumbnail

Efficacy and Safety of Antithrombotic Strategies in Patients With Atrial Fibrillation and Recent ACS or PCI With and Without A History of Heart Failure: Insights From the AUGUSTUS Trial

Speaker: Doctor M. Fudim (Durham, US)

Access
Slides
Video
Thumbnail

Nurse Intervention for Less Chronic Heart Failure Study

Speaker: Professor S. Stewart (Adelaide, AU)

Access
Slides
Video
Thumbnail

Efficacy of omecamtiv mecarbil in heart failure with reduced ejection fraction according to N-terminal pro-B-type natriuretic peptide level: Insights from the GALACTIC-HF trial.

Speaker: Professor J. McMurray (Glasgow, GB)

Access
Slides
Video
Thumbnail

Access the full session

Clinical Trial Updates

Speakers: Professor A. Mebazaa, Professor G. Felker, Associate Professor C. DeFilippi, Doctor M. Fudim, Professor S. Stewart...
Access
Thumbnail

About the event

Image

Heart Failure 2021

29 June - 1 July 2021

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb